Evidence map›Paper›PMID 35426363›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Valerija Tkalec, Virginie Viprey, Georgina Davis, Sandra Janezic, Béatrice Sente, Nathalie Devos, Mark Wilcox, Kerrie Davies, Maja Rupnik, COMBACTE-CDI consortium

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Microbiology spectrum · 2026
    Article
  3. Increase ofMicrobiology spectrum · 2025
    Article
  4. The Role ofMicroorganisms · 2025
    Review
  5. Microbial genomics · 2025
    Article
  6. Distribution ofEmerging microbes & infections · 2024
    Article
  7. Diversity ofApplied and environmental microbiology · 2024
    Article
  8. Antimicrobial susceptibility inJAC-antimicrobial resistance · 2024
    Article
  9. Article
  10. Le infezioni in medicina · 2024
    Review
  11. Microorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Valerija TkalecNational Laboratory for Health, Environment and Food, Maribor, Slovenia.
Virginie VipreyLeeds Institute of Medical Research, University of Leeds, United Kingdom.
Georgina DavisLeeds Institute of Medical Research, University of Leeds, United Kingdom.
Sandra JanezicNational Laboratory for Health, Environment and Food, Maribor, Slovenia.
Béatrice SenteGSK Vaccines, Rixensart, Belgium.
Nathalie DevosGSK Vaccines, Rixensart, Belgium.
Mark WilcoxLeeds Institute of Medical Research, University of Leeds, United Kingdom.
Kerrie DaviesLeeds Institute of Medical Research, University of Leeds, United Kingdom.
Maja RupnikNational Laboratory for Health, Environment and Food, Maribor, Slovenia.
COMBACTE-CDI consortiumThe members of the COMBACTE-CDI consortium are acknowledged at the end of the article.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundWhile human-to-human transmission of

Indexed as

Clostridioides difficileClostridium InfectionsSolanum tuberosumAnimalsClostridioidesEuropeHumansPolymerase Chain ReactionRibotypingClostridioides difficileClostridium difficilefoodfood chainOne Healthpotatovegetables

Identifiers

PMID35426363
PMCPMC9012089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.